Our study suggests that BCL-2 and BAX expression may be helpful in the assessment of the proliferative rate potential of OC cell lines, and highlighted that the development of new therapeutic strategies for the OC should focus on the individual molecular and genetic characteristics of different tumor subtypes. The gene discussed is BAX; the disease is neoplasm.